Escalating Doses of Memantine in Down Syndrome (MEDS-123)

Clinical trial NCT07531940 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07531940
Sponsor: University Hospitals Cleveland Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Down Syndrome Intellectual Disability

Start date: 2026-06-01
Primary completion: 2028-05-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.